ArticleFrontiers in oncology2025

Case Report: Malignant peritoneal mesothelioma with TFG-ROS1 fusion responds to crizotinib.

Wei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.